The Genes Way to Treat Yourself this Black Friday
NV
3 min read
32

The Genes Way to Treat Yourself this Black Friday

November 29, 2024
0

Reading Time: 2 minutes The end of the year calls for replenishment and revelry. The holiday spirit, festive soirees and intimate gatherings with friends and family make room for adding value to our wardrobe – clothes that are crafted consciously and help us put our best foot forward. For

Continue Reading
Nightingale Health announces opening of its Singapore laboratory
CSP
3 min read
13

Nightingale Health announces opening of its Singapore laboratory

November 29, 2024
0

Reading Time: 2 minutes Nightingale Health PlcPress release29 November 2024 at 11:30 a.m. (EET) Nightingale Health, a pioneer in disease risk detection and preventative health announces the opening of its Singapore laboratory: the opening ceremony that will be held on Monday 2nd December 2024

Continue Reading
EQT Exeter completes Spanish student housing portfolio sale to Azora
CSP
6 min read
12

EQT Exeter completes Spanish student housing portfolio sale to Azora

November 29, 2024
0

Reading Time: 4 minutes Since the creation of the portfolio in May 2021, it has grown from two assets with 1,500 beds to 12 assets with 4,100 beds Transaction marks the first sale of EQT Exeter’s living assets in Spain, a market experiencing continued growth

Continue Reading
Empowering India’s Future on Safer Roads
NV
3 min read
33

Empowering India’s Future on Safer Roads

November 29, 2024
0

Reading Time: 2 minutes India grapples with a staggering road safety crisis, recording over 1.7 lakh fatalities annually, with young individuals making up a significant portion of these tragedies. Alarmingly, 29 children lose their lives daily due to road accidents, highlighting an urgent need for structured education and awareness

Continue Reading
CSP
18 min read
10

Visma Announces all-cash voluntary recommended public takeover offer for Penneo

November 29, 2024
0

Reading Time: 12 minutes Company Release no. 19/2024 Copenhagen, Denmark, 29 November 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. Penneo

Continue Reading
VeriSilicon Partners With LVGL to Enable Advanced GPU Acceleration for Wearable Devices and Beyond
BWI
4 min read
27

VeriSilicon Partners With LVGL to Enable Advanced GPU Acceleration for Wearable Devices and Beyond

November 29, 2024
0

Reading Time: 3 minutes Shanghai, China:   VeriSilicon (688521.SH) today announced a strategic partnership with LVGL, the leading open-source graphics library for embedded systems, to support VeriSilicon’s low-power 3D and VGLite 2.5D GPU technology within the LVGL library. This partnership aims to optimize performance and expand

Continue Reading
Crayon Appointed as AWS Authorized Distributor for the European Economic Area, including Switzerland
CSP
3 min read
11

Crayon Appointed as AWS Authorized Distributor for the European Economic Area, including Switzerland

November 29, 2024
0

Reading Time: 2 minutes Crayon builds on its existing distribution expertise to enable partners across new regions to innovate and scale on Amazon Web Services (AWS). Crayon, a global leader in IT services and innovation, today announced its appointment as an AWS Authorized Distributor for

Continue Reading
Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
BWI
10 min read
30

Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis

November 29, 2024
0

Reading Time: 7 minutes Zug, Switzerland:   Full results from the phase III OLYMPIA 1 trial evaluating the efficacy and safety of nemolizumab in adults with moderate-to-severe prurigo nodularis have been published in JAMA Dermatology, showing the trial met all primary and key secondary endpoints1

Continue Reading
CSP
18 min read
10

SyntheticMR resolves on a rights issue of approximately SEK 65 million

November 28, 2024
0

Reading Time: 12 minutes THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR

Continue Reading
CSP
12 min read
10

Notice of extra general meeting in SyntheticMR AB (publ)

November 28, 2024
0

Reading Time: 8 minutes The shareholders of SyntheticMR AB (publ), reg. no. 556723-8877, (the “Company“) are hereby invited to the extra general meeting on Tuesday 17 December 2024 at 13:00 CET at the Company’s premises on Storgatan 11 in Linköping. Right to attend the general

Continue Reading